Latest News of KYTX
institutional investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) must be disappointed after last week's 18% drop
By Yahoo! Finance |
6 days ago
Analyzing ownership data and analyst forecasts provides insights into stock opportunities. Institutional investors hold a 40% stake in Kyverna Therapeutics, impacting stock performance. Understanding ...
Kyverna Therapeutics (KYTX): Leading Nano Cap with Promising CAR T-Cell Therapy
By Yahoo! Finance |
1 month ago
The article discusses the potential of Kyverna Therapeutics, Inc. as one of the best nano cap stocks to invest in, focusing on its innovative therapies for autoimmune diseases. The company's progress,...
We Think Kyverna Therapeutics (NASDAQ:KYTX) Can Afford To Drive Business Growth
By Yahoo! Finance |
3 months ago
Investing in unprofitable companies like Amazon can yield profits, but risks exist. Analyzing Kyverna Therapeutics' cash burn, with a 5.5-year cash runway, shows promise. However, the increasing cash ...